Patient-reported satisfaction with thermal water-based cosmetic products in breast cancer patients undergoing chemotherapy: a feasibility study

IF 3.5 Q3 Medicine

Cancer treatment and research communications Pub Date : 2026-01-01 Epub Date: 2026-03-04 DOI:10.1016/j.ctarc.2026.101168

Judith Passildas , Catherine Abrial , Ioana Molnar , Marie-Ange Mouret-Reynier , Joffrey Chalaphy , Michael Klein , Xavier Durando

{"title":"Patient-reported satisfaction with thermal water-based cosmetic products in breast cancer patients undergoing chemotherapy: a feasibility study","authors":"Judith Passildas , Catherine Abrial , Ioana Molnar , Marie-Ange Mouret-Reynier , Joffrey Chalaphy , Michael Klein , Xavier Durando","doi":"10.1016/j.ctarc.2026.101168","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Chemotherapy and radiotherapy often lead to cutaneous toxicities, which can significantly affect the quality of life of breast cancer patients. Dermatologic side effects of chemotherapy remain an unexplored area of supportive oncology care. This feasibility study aims to assess the patient’s satisfaction and tolerability of thermal water-based cosmetic products for managing chemotherapy-induced skin problems.</div></div><div><h3>Design</h3><div>This prospective, single-center feasibility study included 30 women with non-metastatic breast cancer receiving chemotherapy. Patients were provided with thermal water-based body care products during chemotherapy and spa therapy.</div></div><div><h3>Endpoints</h3><div>Feasibility was assessed by evaluating satisfaction, compliance, and tolerability using visual analogue scales and self-reported questionnaires at the end of chemotherapy (primary) and spa treatment (secondary).</div></div><div><h3>Results</h3><div>At the end of chemotherapy, the mean satisfaction score was 7.52 (<em>n</em> = 23), and after spa treatment, it was 7.15 (<em>n</em> = 13). Compliance rates were 83% during chemotherapy and 54% during spa treatment. Notably, 64% of patients reported improvement in dermatological side effects, including dryness and tightness. Additionally, 69% of patients expressed interest in continuing the use of the products.</div></div><div><h3>Conclusion</h3><div>Thermal water-based cosmetic products demonstrated good satisfaction rate among breast cancer patient with good compliance, tolerability, and moisturizing effects. These findings support the feasibility of the study and suggest a potential benefit of thermal water-based cosmetics in managing chemotherapy-induced skin toxicities. However, these results should be interpreted with caution, as no comparator and no validated dermatologic measures were used. Further studies with robust methodology (i.e., larger sample sizes, comparator and validated dermatologic measures) are needed.</div></div>","PeriodicalId":9507,"journal":{"name":"Cancer treatment and research communications","volume":"47 ","pages":"Article 101168"},"PeriodicalIF":3.5000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468294226000791","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Aims

Chemotherapy and radiotherapy often lead to cutaneous toxicities, which can significantly affect the quality of life of breast cancer patients. Dermatologic side effects of chemotherapy remain an unexplored area of supportive oncology care. This feasibility study aims to assess the patient’s satisfaction and tolerability of thermal water-based cosmetic products for managing chemotherapy-induced skin problems.

Design

This prospective, single-center feasibility study included 30 women with non-metastatic breast cancer receiving chemotherapy. Patients were provided with thermal water-based body care products during chemotherapy and spa therapy.

Endpoints

Feasibility was assessed by evaluating satisfaction, compliance, and tolerability using visual analogue scales and self-reported questionnaires at the end of chemotherapy (primary) and spa treatment (secondary).

Results

At the end of chemotherapy, the mean satisfaction score was 7.52 (n = 23), and after spa treatment, it was 7.15 (n = 13). Compliance rates were 83% during chemotherapy and 54% during spa treatment. Notably, 64% of patients reported improvement in dermatological side effects, including dryness and tightness. Additionally, 69% of patients expressed interest in continuing the use of the products.

Conclusion

Thermal water-based cosmetic products demonstrated good satisfaction rate among breast cancer patient with good compliance, tolerability, and moisturizing effects. These findings support the feasibility of the study and suggest a potential benefit of thermal water-based cosmetics in managing chemotherapy-induced skin toxicities. However, these results should be interpreted with caution, as no comparator and no validated dermatologic measures were used. Further studies with robust methodology (i.e., larger sample sizes, comparator and validated dermatologic measures) are needed.

查看原文本刊更多论文

乳腺癌化疗患者对热水基化妆品的满意度：一项可行性研究

化疗和放疗往往会导致皮肤毒性，严重影响乳腺癌患者的生活质量。化疗的皮肤副作用仍然是支持肿瘤治疗的一个未开发的领域。本可行性研究旨在评估患者对热水基化妆品治疗化疗引起的皮肤问题的满意度和耐受性。这项前瞻性、单中心可行性研究纳入了30名接受化疗的非转移性乳腺癌患者。在化疗和水疗治疗期间，为患者提供热水基身体护理产品。在化疗（主要）和水疗治疗（次要）结束时，采用视觉模拟量表和自我报告问卷，通过评估满意度、依从性和耐受性来评估可行性。结果化疗结束时满意度平均为7.52分（n = 23），水疗治疗后满意度平均为7.15分（n = 13）。化疗依从率为83%，spa治疗依从率为54%。值得注意的是，64%的患者报告皮肤副作用改善，包括干燥和紧绷。此外，69%的患者表示有兴趣继续使用这些产品。结论热水基化妆品在乳腺癌患者中具有良好的依从性、耐受性和保湿效果，满意率较高。这些发现支持了这项研究的可行性，并表明热水基化妆品在控制化疗引起的皮肤毒性方面具有潜在的益处。然而，这些结果应该谨慎解释，因为没有使用比较物和有效的皮肤测量。需要采用稳健的方法（即更大的样本量、比较器和经过验证的皮肤病学测量）进行进一步的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer treatment and research communications Medicine-Oncology

CiteScore

4.30

自引率

0.00%

发文量

148

审稿时长

56 days

期刊介绍： Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.